Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 733,000 | 726,000 | 705,000 | 1,021,000 | 429,000 |
| Marketable Securities | 3,218,000 | 3,962,000 | 3,118,000 | 3,429,000 | 2,859,000 |
| Receivables | 5,960,000 | 4,845,000 | 3,628,000 | 3,960,000 | 4,470,000 |
| Inventories | 3,022,000 | 2,593,000 | 2,402,000 | 2,105,000 | 2,156,000 |
| TOTAL | $12,933,000 | $12,126,000 | $9,853,000 | $10,515,000 | $9,914,000 |
| Non-Current Assets | |||||
| PPE Net | 7,536,000 | 6,597,000 | 5,409,000 | 4,957,000 | 5,981,000 |
| Investments And Advances | 220,000 | 46,000 | 23,000 | 11,000 | 185,000 |
| Other Non-Current Assets | 2,884,000 | 2,807,000 | 2,700,000 | 2,951,000 | 3,736,000 |
| TOTAL | $10,640,000 | $9,450,000 | $8,132,000 | $7,919,000 | $9,902,000 |
| Total Assets | $23,573,000 | $21,576,000 | $17,985,000 | $18,434,000 | $19,816,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 34,000 |
| Accounts payable and accrued liabilities | 7,543,000 | 7,699,000 | 6,159,000 | 6,683,000 | 0 |
| Other current liabilities | 0 | 314,000 | 107,000 | 88,000 | 6,640,000 |
| TOTAL | $7,695,000 | $8,215,000 | $6,480,000 | $6,897,000 | $7,019,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 303,000 | 328,000 | 635,000 | 631,000 | 739,000 |
| aiOther Non-Current Liabilities | 2,397,000 | 1,861,000 | 1,048,000 | 1,364,000 | 502,000 |
| TOTAL | $2,700,000 | $2,189,000 | $1,683,000 | $1,995,000 | $1,242,000 |
| Total Liabilities | $10,395,000 | $10,404,000 | $8,163,000 | $8,892,000 | $8,261,000 |
| Shareholders' Equity | |||||
| Common Shares | 423,000 | 429,000 | 436,000 | 442,000 | 444,000 |
| Retained earnings | 10,449,000 | 8,451,000 | 7,104,000 | 6,957,000 | 8,538,000 |
| Other shareholders' equity | 1,857,000 | 1,889,000 | 1,948,000 | 1,908,000 | 2,371,000 |
| TOTAL | $13,178,000 | $11,172,000 | $9,822,000 | $9,542,000 | $11,555,000 |
| Total Liabilities And Equity | $23,573,000 | $21,576,000 | $17,985,000 | $18,434,000 | $19,816,000 |